InvestorsHub Logo
icon url

tarballmonger

04/19/18 5:48 PM

#43059 RE: TMEvans #43058

these are.
icon url

StevenRisk

04/19/18 5:55 PM

#43060 RE: TMEvans #43058

I agree. It is like doing a secondary at $1.20 a share. The last dilution was at .60 a share. Had we done that deal at $1.20 we would have 5.5 mil less dilution. Also no interest either.

Yes Tarball this is much better financing by a country mile. As far as revenues we will see a nice increase in Q2 but the revenues will be substantially higher Q4.

This is by far the best deal to date. We are basically paying $2 Mil for 50% and selling 1.29 Mil for $1.5 Mil. So in essence if I read this right we will spend around $500K for 50% ownership and then receive $1.50 Mil. for 1.29 Mil Shares with a licensed lab in a country that is going legal.

So in total we spend $500k and give a line of credit for $1.0 Mil.
icon url

GangstaRIB

04/19/18 6:53 PM

#43063 RE: TMEvans #43058

At the end of the day they all are but the question is will shares become part of the float or be held tightly by insiders? The dilution on it's own does not typically affect pps right away, however, selling shares obviously does.

I'm having a hard time figuring out that part of the deal. Shares will be sold to the CA lab, however, EVIO is then loaning back the money? Sounds a bit odd, but maybe the company needed cash flow right away and also wanted a stake in EVIO.